News &
Publications

Contacts

Franklin Hoke
Vice President
for Communications
215-728-2700
215-475-2888 (cell phone)
Franklin.Hoke@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Fox Chase Cancer Center Names New Director of Clinical Research for Radiation Oncology

PHILADELPHIA (January 4, 2005) -- Andre A. Konski, MD, MBA, MA, of Fort Washington, Pa., has been named clinical research director for the Department of Radiation Oncology at Fox Chase Cancer Center. He is responsible for overseeing the administration of national cooperative and Fox Chase Cancer Center investigator-initiated clinical trials within the department of radiation oncology.

Konski also is clinical director of the Prostate Cancer Risk-Assessment Program. The three main goals of the program are to provide close monitoring to detect any prostate tumors at the earliest and most curable stage; to offer education about prostate-cancer risks, clustering of cancers within a family and why this occurs; and to help the next generation of men likely to be affected by prostate cancer.

Konski joined Fox Chase is 2002. After receiving his BA from Saint Michael's College in Winooski, Vt., in 1980, Konski earned his MD from New York Medical College in 1984. He interned and completed his residency in radiation oncology at Strong Memorial Hospital in Rochester, N.Y., where he was chief radiation oncology resident from 1987 to 1988. During this time, he also held an American Cancer Society clinical oncology fellowship.

Later, at the University of Toledo, he earned his master's in business administration in 1995 and his M.A. in economics in 1998. He received the University of Toledo College of Business Pacemaker Award and was elected to the Phi Kappa Phi and Beta Gamma Sigma honorary societies in 1994.

Konski is active in the Radiation Therapy Oncology Group (RTOG), a national group sponsoring clinical trials using radiation therapy for cancer patients. He currently chairs the economics subcommittee of RTOG's committee on treatment outcomes. He also serves on RTOG's research strategy committee.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 2005 News Releases »